These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36542951)

  • 1. Mesoporous polydopamine-based nanoplatform for enhanced tumor chemodynamic therapy through the reducibility weakening strategy.
    Zhang Q; Xu X; Yang Q; Duan Y; Chen C; Zhao S; Ouyang Y; Chen Y; Cao Y; Liu H
    Colloids Surf B Biointerfaces; 2023 Feb; 222():113091. PubMed ID: 36542951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasmall Gold-Coated Mesoporous Polydopamine Nanoprobe to Enhance Chemodynamic Therapy by Self-Supplying H
    Wang Z; Shi Y; Shi Y; Zhang J; Hao R; Zhang G; Zeng L
    ACS Appl Mater Interfaces; 2022 Dec; 14(49):54478-54487. PubMed ID: 36448730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomimetic Yolk-Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic Therapy of Cancer.
    Pan Y; Zhu Y; Xu C; Pan C; Shi Y; Zou J; Li Y; Hu X; Zhou B; Zhao C; Gao Q; Zhang J; Wu A; Chen X; Li J
    ACS Nano; 2022 Nov; 16(11):19038-19052. PubMed ID: 36315056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous polydopamine delivery system for intelligent drug release and photothermal-enhanced chemodynamic therapy using MnO
    Wang Z; Li Z; Shi Y; Zeng L
    Regen Biomater; 2023; 10():rbad087. PubMed ID: 37936892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
    Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
    Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
    Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-responsive and NIR-driven free radical nanoamplifier with glutathione depletion for enhanced tumor-specific photothermal/thermodynamic/chemodynamic synergistic Therapy.
    Chen F; Zhang X; Wang Z; Xu C; Hu J; Liu L; Zhou J; Sun B
    Biomater Sci; 2022 Oct; 10(20):5912-5924. PubMed ID: 36040793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H
    Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO
    Lin LS; Song J; Song L; Ke K; Liu Y; Zhou Z; Shen Z; Li J; Yang Z; Tang W; Niu G; Yang HH; Chen X
    Angew Chem Int Ed Engl; 2018 Apr; 57(18):4902-4906. PubMed ID: 29488312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endo/exo-genous dual-stimuli responsive gold nanotetrapod-based nanoprobe for magnetic resonance imaging and enhanced multimodal therapeutics by amplifying·OH generation.
    Shi Y; Zeng L; Pan Y; Zhang H; Wang Z; Shi Y; Wu A
    Acta Biomater; 2022 Dec; 154():549-558. PubMed ID: 36243375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-loaded mesoporous polydopamine nanoparticles capped with MnO
    Zhang Y; Williams GR; Wang T; Zheng Y; Xu J; Nguyen VC; Yao L; Wang H; Zhu LM
    Int J Pharm; 2024 May; 656():124093. PubMed ID: 38583822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
    Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
    Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen-supplementing mesoporous polydopamine nanosponges with WS
    Wang Y; Song S; Lu T; Cheng Y; Song Y; Wang S; Tan F; Li J; Li N
    Biomaterials; 2019 Nov; 220():119405. PubMed ID: 31408811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional MnO
    Wang Q; Qu B; Li J; Liu Y; Dong J; Peng X; Zhang R
    ACS Appl Mater Interfaces; 2022 Feb; 14(4):4980-4994. PubMed ID: 35050589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mesoporous MnO
    Zhang HL; Wang Y; Tang Q; Ren B; Yang SP; Liu JG
    J Inorg Biochem; 2023 Apr; 241():112133. PubMed ID: 36708626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance self-cascade nanoreactors for combined ferroptosis, photothermal therapy, and starving therapy.
    Huang QF; Li YH; Huang ZJ; Wu QX; Mei J; Wang W; Gui P; Cheng F; Wang GH
    Eur J Pharm Biopharm; 2024 Aug; 201():114367. PubMed ID: 38876360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours.
    Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X
    J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of oxidative stress with a hyperthermia-enhanced chemodynamic process and MTH1 inhibition for sequential tumor nanocatalytic therapy.
    Song Q; Zhang Y; Deng X; Zhao H; Zhang Y; Li J; Chen W; Hu H; Zhang Y
    J Mater Chem B; 2023 May; 11(17):3836-3850. PubMed ID: 36976579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenton-like reaction and glutathione depletion by chiral manganese dioxide nanoparticles for enhanced chemodynamic therapy and chemotherapy.
    Gao F; Sun M; Zhang J; Chang Y; Gao W; Ma G; Ma X; Guo Y
    J Colloid Interface Sci; 2022 Jun; 616():369-378. PubMed ID: 35220185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation.
    Wang TH; Shen MY; Yeh NT; Chen YH; Hsu TC; Chin HY; Wu YT; Tzang BS; Chiang WH
    J Colloid Interface Sci; 2023 Nov; 650(Pt B):1698-1714. PubMed ID: 37499626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.